Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lenders

Showing results (201-210 of 253) with videos related to

Pageof 26
Sort By:
Neurology|January 28, 2004
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trialR A J Esselink, R M A de Bie, R J de Haan, et al.
The Journal of Applied Laboratory Medicine|March 27, 2024
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient StudySybille Fuld, Georgiana Constantinescu, Christina Pamporaki, et al.
European Journal of Endocrinology|August 2, 2019
Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicionAikaterini Geroula, Timo Deutschbein, Katharina Langton, et al.
Annals of Clinical Biochemistry|October 16, 2012
Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytomaGraeme Eisenhofer, Peter Lattke, Maria Herberg, et al.
Journal of Hypertension|July 24, 2025
The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronismChristina Pamporaki, Hanna Remde, Georgiana Constantinescu, et al.
Neurology|August 10, 2012
Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau diseaseCarlijn Frantzen, Roeliene C Kruizinga, Sophie J van Asselt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2022
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paragangliomaChristina Pamporaki, Tamara Prodanov, Leah Meuter, et al.
Human Pathology|May 15, 2020
Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer ReportingLester D R Thompson, Anthony J Gill, Sylvia L Asa, et al.
International Journal of Cancer|March 29, 2014
Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor XNan Qin, Aguirre A de Cubas, Ruben Garcia-Martin, et al.
Journal of Inherited Metabolic Disease|October 9, 2020
Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiencyTessa Wassenberg, Jaap Deinum, Frans J van Ittersum, et al.
Pageof 26

Showing results (201-210 of 253) with videos related to

Sort By:
Pageof 26
Neurology|January 28, 2004
Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trialR A J Esselink, R M A de Bie, R J de Haan, et al.
The Journal of Applied Laboratory Medicine|March 27, 2024
Screening for Primary Aldosteronism by Mass Spectrometry Versus Immunoassay Measurements of Aldosterone: A Prospective Within-Patient StudySybille Fuld, Georgiana Constantinescu, Christina Pamporaki, et al.
European Journal of Endocrinology|August 2, 2019
Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicionAikaterini Geroula, Timo Deutschbein, Katharina Langton, et al.
Annals of Clinical Biochemistry|October 16, 2012
Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytomaGraeme Eisenhofer, Peter Lattke, Maria Herberg, et al.
Journal of Hypertension|July 24, 2025
The saline infusion test with mass spectrometric measurements of aldosterone to confirm primary aldosteronismChristina Pamporaki, Hanna Remde, Georgiana Constantinescu, et al.
Neurology|August 10, 2012
Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau diseaseCarlijn Frantzen, Roeliene C Kruizinga, Sophie J van Asselt, et al.
European Journal of Cancer (Oxford, England : 1990)|May 2, 2022
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paragangliomaChristina Pamporaki, Tamara Prodanov, Leah Meuter, et al.
Human Pathology|May 15, 2020
Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer ReportingLester D R Thompson, Anthony J Gill, Sylvia L Asa, et al.
International Journal of Cancer|March 29, 2014
Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor XNan Qin, Aguirre A de Cubas, Ruben Garcia-Martin, et al.
Journal of Inherited Metabolic Disease|October 9, 2020
Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiencyTessa Wassenberg, Jaap Deinum, Frans J van Ittersum, et al.
Pageof 26